Biofourmis has been shaping vital innovations since 2015. Every day, this company challenges itself to create a healthful future where equitable access to care is a reality for all. Powered by its innovative technology platform, Biofourmis offers connected, configurable, and individualized care options, managed both virtually and in-person for patients at home. For healthcare providers and risk-bearing entities, Biofourmis improves clinical, operational, and economic outcomes across the care continuum.

This organization designed its technology and services platform for precision and flexibility. Driven by data and FDA-cleared algorithms, the Biofourmis platform delivers interventions personalized to the individual and their disease. It’s configurable and scalable, to adapt to the needs of the client’s organization and patient populations. For all aspects of drug development and care delivery, the Biofourmis platform helps make care simpler, science smarter, and patients healthier.

Salient solutions offered by Biofourmis

Hospital at home: Using dynamic care pathways, continuous monitoring, care coordination tools, and configurable services, Biofourmis enable clinicians to deliver inpatient-level care at home.

Biofourmis Care can help the healthcare partners to:

• Improve clinical outcomes with lower rates of mortality
• Increase bed-days saved and create capacity for more acute patients
• Increase patient satisfaction by treating patients where they are most comfortable
• Deliver remote care similar to inpatient workflows through EMR integration
• Utilize a coordinated network of in-home partners providing services such as: nursing, phlebotomy, infusion, wound care, and other ancillary services
• Maximize patient-to-staff ratio with a scalable, technology-enabled platform

Transitional Care: Biofourmis’ transitional care solutions allow patients to move seamlessly from acute to ambulatory to chronic care management, virtually and at home.
Biofourmis provide:

• AI-guided software and clinically-actionable notifications help dedicated, licensed, clinical care teams detect and intervene sooner
• Episodic or continuous monitoring leveraging a device-agnostic portfolio of FDA-cleared devices
• Improved patient engagement enabled by the patient app, featuring task reminders, symptom tracking questionnaires, educational content, and adherence tracking
• Time-sensitive patient outreach via text, talk, and video conferencing capability
• Utilize a coordinated network of in-home partners providing services such as: nursing, phlebotomy, infusion, wound care, and other ancillary services*
• Disease-specific pathways including cardio-metabolic, pulmonary, oncologic, infectious disease, and post-procedure transitional conditions

Digital Disease Management: Biofourmis offer virtual, value-based care for patients with chronic conditions, and streamlined patient management for clinicians.
It enhances the partners’ organizational capacity, staff efficiency, profitability, and quality of care with:

• A broad range of monitoring through clinically validated devices that enable continuous data capture
• Advanced analytics that improve medication optimization for more personalized clinical care
• Remote care for patients with cardio-metabolic, oncologic, and pulmonary conditions
• Omnipresent support for patients from the national provider network of MDs, RNs, NPs, and Health Navigators, who engage patients to help ensure compliance and clinical goals
• Scalable care management capabilities that improves patient satisfaction and patient engagement
• Population health-based, disease specific care pathways for patient identification help improve care coordination and quality measures

Virtual Specialty Care: The virtual specialty care solution comprises a network of specialists, in-home services, and devices to extend and complement ambulatory specialty care for patients.
It includes:

• Access to a virtual network of specialists and care teams (MD, RN, APP; ancillary health support services)
• Automated recommendation tool for medication optimization
• Telehealth visits that provide virtual triage and consults
• Digital tools for patient self-management
• Remote patient monitoring 

Digital Clinical Trials: The technology-enabled, scalable clinical research platform supports trial decentralization, precision participant recruitment, and equitable access to treatment options for patients everywhere.

Biofourmis’ partners can:

• Accelerate recruitment and raise rates of research participation through the growing global network of health system partners and sites
• Ease patient burden and improve retention with digital patient engagement tools, and integrated in-home healthcare delivery and study visits
• Accelerate clinical development with remote data collection and novel digital endpoints from the library of biomarkers across multiple therapeutic areas
• Monitor and manage side effects, adverse events, and other safety concerns
• Collect real-world evidence to inform R&D, commercial decision making, and lifecycle line extension

Digital Drug Companions: Biofourmis help the partners develop and commercialize novel digital companion technologies that enhance traditional drug therapies, such as digital biomarkers that track pain or identify cardiac events. 

By studying the efficacy and expanding the use of these advances, the partners accumulate evidence and market differentiation for their products through:

• Developing and integrating digital biomarkers and SaMD into established care pathways
• Monitoring and management of side effects, adverse events, and other safety concerns to mitigate risk and enable patients to avoid hospital stays during therapy
• Algorithm-guided recommendations for therapy titration and dose optimization based on individual’s data and baseline to drive precision medicine delivery
• Digital patient engagement programs for personalized condition management and improved patient adherence

Market Access Solutions: Biofourmis offer care pathway integration for approved therapies to help ensure that patients have access to the right treatment when and where they need it.
The partners benefit from:

• Patient identification through the growing network of health system partners to find therapy candidates and to drive both clinical and commercial outcomes
• Integration into the disease-specific dynamic care pathways to optimize care delivery
• Virtual visits and digital patient support programs to drive patient adherence to therapeutic protocols
• In-home therapy administration, monitoring, and services with Biofourmis Care
• Observational data and surveillance to support FDA post-market drug safety monitoring

Access: Without geographic and economic barriers, a more diverse patient pool can take part in clinical trials and receive the care they need.

Safety: Remote patient management helps maintain protocol adherence and identify clinical deviations, improving patient experience and safety.

Support: Virtual visits from health and wellness professionals along with coordinated digital patient experience programs offer timely education and guidance on the patient’s specific condition.

Savings: Reduced travel costs and time to clinics and trial sites for patients and caregivers.

Engagement: Increased patient engagement via daily personal care plans, progress tracking, and ongoing patient-specific education.

Maulik Majmudar, MD, Co-founder and Chief Medical Officer 

“To harness the power of technology and data to shape innovations that bring the right care to every person, no matter where they are.”